| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Clinical and Molecular Hepatology Search > Browse Articles > Search



Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection
Shinya Sato, Kei Moriya, Masanori Furukawa, Soichiro Saikawa, Tadashi Namisaki, Mitsuteru Kitade, Hideto Kawaratani, Kosuke Kaji, Hiroaki Takaya, Naotaka Shimozato, Yasuhiko Sawada, Kenichiro Seki, Koh Kitagawa, Takemi Akahane, Akira Mitoro, Yasushi Okura, Junichi Yamao, Hitoshi Yoshiji
Clin Mol Hepatol.2019;25(1):65-73.   Published online February 25, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0070
                              
Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study
Young Min Kim, Suk Bae Kim, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae, Myeong Jun Song, Ji Woong Jang, Soon Young Ko, Jae Dong Lee
Clin Mol Hepatol.2018;24(3):311-318.   Published online June 4, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0070
                                 Cited By 2
Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans?
Jong Eun Yeon
Clin Mol Hepatol.2018;24(3):294-296.   Published online September 11, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1009
                              
Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy
Soon Jae Lee, Yoo-Kyung Cho, Soo-Young Na, Eun Kwang Choi, Sun Jin Boo, Seung Uk Jeong, Hyung Joo Song, Heung Up Kim, Bong Soo Kim, Byung-Cheol Song
Clin Mol Hepatol.2016;22(3):390-395.   Published online August 30, 2016     
DOI: https://doi.org/10.3350/cmh.2015.0050
                                 Cited By 1
Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea
Suh Yoon Yang, Hyun Woong Lee, Youn Jae Lee, Sung Jae Park, Ki Young Yoo, Hyung Joon Kim
Clin Mol Hepatol.2015;21(2):125-130.   Published online June 26, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.2.125
                                 Cited By 2
Hepatitis C virus infection in patients with hemophilia in Korea: Is antiviral therapy effective and safe?
Woo Sun Rou, Byung Seok Lee
Clin Mol Hepatol.2015;21(2):122-124.   Published online June 26, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.2.122
                              
High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice
Nae-Yun Heo, Young-Suk Lim, Han Chu Lee, Yung Sang Lee, Kang Mo Kim, Kwan Soo Byun, Kwang-Hyub Han, Kwan Sik Lee, Seung Woon Paik, Seung Kew Yoon, Dong Jin Suh
Clin Mol Hepatol.2013;19(1):60-69.   Published online March 25, 2013     
DOI: https://doi.org/10.3350/cmh.2013.19.1.60
                                 Cited By 5
Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?
Young Kul Jung, Ju Hyun Kim
Clin Mol Hepatol.2013;19(1):26-28.   Published online March 25, 2013     
DOI: https://doi.org/10.3350/cmh.2013.19.1.26
                                 Cited By 4
Efficacy of peginterferon and ribavirin is associated with the IL28B gene in Korean patients with chronic hepatitis C
Seok Hoo Jeong, Young Kul Jung, Jae Won Yang, Sang Jin Park, Jong Woo Kim, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim
Clin Mol Hepatol.2012;18(4):360-367.   Published online December 21, 2012     
DOI: https://doi.org/10.3350/cmh.2012.18.4.360
                                 Cited By 10
A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C
Byung Chul You, Young Seok Kim, Hun il Kim, Se Hun Kim, Seung Sik Park, Yu Ri Seo, Sang Gyune Kim, Se Whan Lee, Hong Soo Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim
Clin Mol Hepatol.2012;18(3):272-278.   Published online September 25, 2012     
DOI: https://doi.org/10.3350/cmh.2012.18.3.272
                                 Cited By 1
Impact of ribavirin dose reduction during treatment in chronic hepatitis C genotype 1 patients
Woo Jin Chung
Clin Mol Hepatol.2012;18(3):268-271.   Published online September 25, 2012     
DOI: https://doi.org/10.3350/cmh.2012.18.3.268
                                 Cited By 1
Rapid normalization of alanine aminotransferase predicts viral response during combined peginterferon and ribavirin treatment in chronic hepatitis C patients
Yun Jung Kim, Byoung Kuk Jang, Eun Soo Kim, Kyung Sik Park, Kwang Bum Cho, Woo Jin Chung, Jae Seok Hwang
Korean J Hepatol.2012;18(1):41-47.   Published online March 22, 2012     
DOI: https://doi.org/10.3350/kjhep.2012.18.1.41
                                 Cited By 6
Recent trends in the treatment of chronic hepatitis C
Dae Won Jun, Won Young Tak, Si Hyun Bae, Youn Jae Lee
Korean J Hepatol.2012;18(1):22-28.   Published online March 22, 2012     
DOI: https://doi.org/10.3350/kjhep.2012.18.1.22
                                 Cited By 7
Peginterferon alpha and ribavirin combination therapy in patients with hepatitis C virus-related liver cirrhosis
Kyung Hoon Kim, Byoung Kuk Jang, Woo Jin Chung, Jae Seok Hwang, Young Oh Kweon, Won Young Tak, Heon Ju Lee, Chang Hyeong Lee, Jeong Ill Suh
Korean J Hepatol.2011;17(3):220-225.   Published online September 30, 2011     
DOI: https://doi.org/10.3350/kjhep.2011.17.3.220
                                 Cited By 11
Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin
Sang Bun Choi, Youn Jae Lee, Jae Ik Lee, Young Jin Song, Byoung Jin Choi, Jong Han Kim, Eun Uk Jung, Sung Jae Park, Sang Heon Lee, Ji Hyun Kim, Jung Sik Choi, Sam Ryong Jee, Sang Yong Seol
Korean J Hepatol.2011;17(3):183-188.   Published online September 30, 2011     
DOI: https://doi.org/10.3350/kjhep.2011.17.3.183
                                 Cited By 3
The Korean Joumal of Peginterferon alfa-2a/ribavirin for 48 or 72 weeks in hepatitis C genotype 1 and 4 patients with slow virologic response
In Hee Kim, M.D.
Korean J Hepatol.2010;16(2):201-205.   Published online June 25, 2010     
DOI: https://doi.org/10.3350/kjhep.2010.16.2.201
         Cited By 1
Clinical efficacy and safety of the combination therapy of peginterferon alpha and ribavirin in cirrhotic patients with HCV infection
Hong Ryeol Cheong, M.D., Hyun Young Woo, M.D., Jeong Heo, M.D., Ki Tae Yoon, M.D., Dong Uk Kim, M.D., Gwang Ha Kim, M.D., Dae Hwan Kang, M.D., Geun Am Song, M.D., Mong Cho, M.D.
Korean J Hepatol.2010;16(1):38-48.   Published online March 26, 2010     
DOI: https://doi.org/10.3350/kjhep.2010.16.1.38
         Cited By 9
A comparison of 24- vs. 48-week peginterferon plus ribavirin in patients with genotype 1 chronic hepatitis C
Mi Na Kim, M.D.1, Ki Tae Yoon, M.D.2,3, Jun Yong Park, M.D.1,3, Do Young Kim, M.D.1,3, Sang Hoon Ahn, M.D.1,3, Chae Yoon Chon, M.D.1,3, Kwang-Hyub Han, M.D.1,3
Korean J Hepatol.2009;15(4):496-503.   Published online December 31, 2009     
DOI: https://doi.org/10.3350/kjhep.2009.15.4.496
         Cited By 2
Impact of adherence to peginterferon-ribavirin combination therapy in chronic hepatitis C patients on achieving a sustained virologic response
Soung Won Jeong, M.D., Jin Dong Kim, M.D.1, Hyun Young Woo, M.D.1, Chan Ran You, M.D.1, Sung Won Lee, M.D.1, Myeong Jun Song, M.D.1, Jung Won Jang, M.D.1, Si Hyun Bae, M.D.1, Jong Young Choi, M.D.1, Seung Kew Yoon, M.D.1
Korean J Hepatol.2009;15(3):338-349.   Published online September 30, 2009     
DOI: https://doi.org/10.3350/kjhep.2009.15.3.338
         Cited By 9
Durability of a sustained virologic response in combination therapy with interferon/peginterferon and ribavirin for chronic hepatitis C
Chul Hyun Kim , Byung Do Park , Jin Woo Lee , Young Soo Kim , Seok Jeong , Don Haeng Lee , Hyung Gil Kim , Yong Woon Shin , Key Sook Kwon , Jung Il Lee
Korean J Hepatol.2009;15(1):70-79.   Published online March 31, 2009     
DOI: https://doi.org/10.3350/kjhep.2009.15.1.70
         Cited By 9
Efficacy of initial treatment with peginterferon alpha-2a versus peginterferon alpha-2b in combination with ribavirin in naive chronic hepatitis C patients Living in Daejeon and Chungcheong Province in Korea: A comparative study
Jeong Il Kim, M.D, Seok Hyun Kim, M.D., Byung Seok Lee, M.D., Heon Young Lee, M.D., Tae Hee Lee, M.D.1, Young Woo Kang, M.D.1, Hyang Ie Lee, M.D.2, An Na Kim, M.D.2, Soon Woo Nam, M.D.3, Byeong Chool Park, M.D.4, Hee Bok Chae, M.D.4, Seok Bae Kim, M.D.5, Il Han Song, M.D.5, Ji Young Park, M.D.6, Hong Su Kim, M.D.6
Korean J Hepatol.2008;14(4):493-502.   Published online December 31, 2008     
DOI: https://doi.org/10.3350/kjhep.2008.14.4.493
         Cited By 9
Treatment of chronic hepatitis C: Efficacy of initial treatment of peginterferon alpha-2a versus peginterferon alpha-2b plus ribavirin in naive chronic hepatitis C patients
Youn Jae Lee
Korean J Hepatol.2008;14(4):443-445.   Published online December 31, 2008     
DOI: https://doi.org/10.3350/kjhep.2008.14.4.443
      
Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection
Myoung Joo Kang, M.D., Eun Uk Jung, M.D., Sang Won Park, M.D., Paul Choi, M.D., Ji Hyun Kim, M.D., Sung Jae Park, M.D., Eun Taek Park, M.D., Youn Jae Lee, M.D., Sang Hyuk Lee, M.D., Sang Yong Seol, M.D.
Korean J Hepatol.2008;14(3):318-330.   Published online September 30, 2008     
DOI: https://doi.org/10.3350/kjhep.2008.14.3.318
         Cited By 17
Clinical outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C
Kyoung Tae Kim , Sang Young Han , Jong Han Kim , Hyun Ah Yoon , Yang Hyun Baek , Min Ji Kim , Sung Wook Lee , Jin Seok Jang , Jong Hun Lee , Myung Hwan Roh
Korean J Hepatol.2008;14(1):36-45.   Published online March 20, 2008     
DOI: https://doi.org/10.3350/kjhep.2008.14.1.36
         Cited By 20
Short-term Therapy with Pegylated Interferon plus Ribavirin for the Chronic Hepatitis C Genotype 2 Patients
Eun Uk Jung , Ji Hun Park , Kyung Im Pae , Suk Woo Kang , Sung Jae Park , Sam Ryong Jee , Eun Tak Park , Youn Jae Lee , Sang Hyuk Lee , Sang Young Seol
Korean J Hepatol.2007;13(3):341-348.   Published online September 20, 2007     
DOI: https://doi.org/10.3350/kjhep.2007.13.3.341
         Cited By 2
Treatment of Chronic Hepatitis C: Shorter Treatment Duration For Genotype 2 or 3 Infection
Sook Hyang Jeong
Korean J Hepatol.2007;13(3):301-303.   Published online September 20, 2007     
DOI: https://doi.org/10.3350/kjhep.2007.13.3.301
      
Peginterferon Alfa-2a plus Ribavirin for Initial Treatment of Chronic Hepatitis C in Korea
Hyuk Lee, M.D., Moon Seok Choi, M.D., Seung Woon Paik, M.D., Jeong Hwan Kim, M.D., Do Young Kim, M.D., Joon Hyoek Lee, M.D., Kwang Cheol Koh, M.D., Byung Chul Yoo, M.D., Jong Chul Rhee, M.D. and Soon Mi Song, R.N.1
Korean J Hepatol.2006;12(1):31-40.
      
Peginterferon-alpha and Ribavirin Combination Therapy in Chronic Hepatitis C
Kwang Hyub Han , Young Hoon Yoon
Korean J Hepatol.2004;10(2):81-87.
      
Recurrence and Management of Hepatitis C after Liver Transplantation
Ki Bong Oh, M.D., Sung Gyu Lee, M.D., Young Joo Lee, M.D., Kwang Min Park, M.D., Shin Hwang, M.D., Ki Hun Kim, M.D., Chul Soo Ahn, M.D., Deok Bog Moon, M.D., Chong Woo Chu, M.D., Hyun Seung Yang, M.D., Tae Yong Ha, M.D. and Sung Hoon Cho, M.D.
Korean J Hepatol.2003;9(3):180-187.
      
Efficacy of Combination of Interferon α 2a , Ribavirin and UDCA in the Treatment of Chronic Hepatitis C
Dong Jin Suh , Neung Hwa Park , Young Hwa Chung , Young Sang Lee
Korean J Hepatol.1998;4(2):109-119.
      
1 |
E-Submission
Email Alert
Author's Index
EndNote Style file download
The Korean Association for the Study of the Liver
The Liver Week 2019
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
DOAJ
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
MeSH on Demand
COPE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.         
COUNTER
TODAY : 644
TOTAL : 67651